The Cancer Letter

Inside information on cancer research and drug development

Vol.
24
No.
5
May 25, 2001May 25, 2001
Free
DOWNLOAD THE PDF

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

Preoperative Chemo Doubles Survival In Locally Advanced Bladder Cancer

Gleevec Approval Sets Record For FDA Review: 73 Days

Advances Found In Treatment Of Aerodigestive Cancers

Silicone Implants Not Linked To Increased Risk Of Death

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

NCI-Approved Clinical Trials Listed For April 2001

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account